Zobrazeno 1 - 9
of 9
pro vyhledávání: '"A., Aranguren Redondo"'
Autor:
L. M. Lopez Dominguez, N. Alcorta Lorenzo, MA Aranguren Redondo, E. Uriarte Isacelaya, A. De Diego Sola, O. Maiz-Alonso, J. J. Cancio Fanlo, M.B. Irastorza Larburu, J. M. Belzunegui Otano, C. A. Egues
Publikováno v:
Annals of the Rheumatic Diseases. 80:1141-1142
Background:Biological disease modifying drugs (bDMARD) has allowed a targeted approach to rheumatoid arthritis (RA). Once sustained remission is achieved, the use of bDMARDs at lower doses than indicated in data sheets is considered (optimized treatm
Autor:
G Lizeaga Cundin, J Landa Alberdi, A Lizardi Mutuberria, MP Bachiller Cacho, MJ Garcia de Andoin Barandiaran, L Leunda Eizmendi, MA Aranguren Redondo, A Zurutuza Lopez, M Urretavizkaya Anton, Dan Garcia, T Gonzalez Fernandez
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background In the pivotal authorisation trial of carfilzomib, patients with severe cardiovascular abnormalities (NYHA III or IV), clinically significant and uncontrolled, were not included. Purpose The aim of this study was to analyse the cardiovascu
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
MJ Gayan Lera, L Lombera Saez, MP Bachiller Cacho, MP Carmona Oyaga, I Aguirre Zubia, MA Aranguren Redondo, M Ercilla Liceaga, A Lizardi Mutuberria, L Leunda Eizmendi, M Ripa Ciaurriz
Publikováno v:
European Journal of Hospital Pharmacy. 22:A67.3-A68
Background A drug adjustment programme for patients with renal disease was started in 2013 in our hospital. In this system, information from the electronic prescription programme is linked (using an Access application) with information sent by the la
Autor:
G Lopez Arzoz, MP Bachiller Cacho, G Liceaga Cundin, MI Fernandez Gonzalez, M.B. Irastorza Larburu, I Aguirre Zubia, O Valbuena Pascual, J Belzunegui Otaño, O. Maiz Alonso, MA Aranguren Redondo
Publikováno v:
European Journal of Hospital Pharmacy. 20:A163.1-A163
Background Drug dosage modifications are a common clinical practise regarding Tumor Necrosis Factor (TNF) blockers, using posologies not specified on the authorised product information summary. This practise has a significant financial impact on the
Autor:
A Aranguren Redondo, B. Odriozola Cincunegui, JA Iribarren Loyarte, G Lopez Arzoz, O Valbuena Pascual, MP Bachiller Cacho, P Carmona Oyaga, P Pascual Gonzalez, MJ Gayan Lera, K Andueza Granados
Publikováno v:
European Journal of Hospital Pharmacy. 20:A170.2-A170
Background Current guidelines (GESIDA/PNS-2012) for antiretroviral therapy (ART) in adults recommend the combination of 3 drugs for the treatment of chronic HIV infection. Purpose To analyse the ART in adult HIV- infected patients monitored in our ho
Autor:
MJ Gayan Lera, I Aguirre Zubia, MC Leunda Eizmendi, MA Aranguren Redondo, MC Andueza Granados, G Lizeaga Cundin, M Barrenetxea Zabala
Publikováno v:
European Journal of Hospital Pharmacy. 20:A194.2-A194
Background Computerized physician order entry (CPOE) implementation in hospitals has become an important tool for interactive validation of medical orders as well as a facilitator for pharmacist interventions. However several studies have investigate
Autor:
C., Ripa Ciaurriz1 cripa@chdo.osakidetza.net, M. J., Arrizabalaga Arrizabalo1, M., Ercilla Liceaga1, P., Bachiller Cacho1, A., Aranguren Redondo1, A., Aguirre Olaizola1, M., Zabarte Martínez de Aguirre2, S., Larburu Echániz3, A., Beguiristain Gómez3, I., Ruiz Montesinos3
Publikováno v:
Nutrición Hospitalaria. may/jun2007 suppleme, Vol. 22, p17-17. 1p.